Therapeutic Implications of Epstein–Barr Virus Infection for the Treatment of Nasopharyngeal Carcinoma

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s47434
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus

Biology, Medicine, & Natural Product Chemistry
2018English

Induction of CCL5 by Epstein-Barr Virus Infection Enhances Tumor Angiogenesis in Nasopharyngeal Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2018English

Requirement for Cell-To-Cell Contact in Epstein-Barr Virus Infection of Nasopharyngeal Carcinoma Cells and Keratinocytes

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1999English

Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing

PLoS ONE
Multidisciplinary
2010English

Treatment of Locally Recurrent Epstein–barr Virus-Associated Nasopharyngeal Carcinoma Using the Anti-Viral Agent Cidofovir

Journal of Medical Virology
VirologyInfectious Diseases
2008English

Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients Before and After Treatment

Clinical Cancer Research
Cancer ResearchOncology
2013English

Twenty-Second Paterson Symposium: Epstein-Barr Virus and the Molecular Biology of Nasopharyngeal Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1988English

Clinical Implications of Plasma Epstein–Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Quantification of Epstein-Barr Virus DNA Load in Nasopharyngeal Brushing Samples in the Diagnosis of Nasopharyngeal Carcinoma in Southern China

Cancer Science
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy